CLINICAL COURSE AND MODERN METHODS OF TREATMENT OF VIRAL HEPATITIS C IN ADOLESCENTS

Yakubova Ranokhon Maksimovna

Authors

Yakubova Ranokhon Maksimovna Assistant of the Department of Infectious Diseases Andijan State Medical Institute, Andijan, Uzbekistan

Keywords:

viral hepatitis C, adolescents, chronic hepatitis C, clinical course, diagnostics, direct-acting antiviral drugs (DAA), interferon, ribavirin, prevention, dispensary observation.

Abstract

Viral hepatitis C (HCV) in adolescents is a pressing health problem due to the possible transition of the infection to a chronic form and the risk of developing serious complications in the future (cirrhosis, hepatocellular carcinoma). This article highlights the features of the clinical course of HCV in adolescence, diagnostic approaches and modern methods of therapy, including the use of direct-acting antiviral drugs (DAA). Issues of prevention and dispensary observation are also considered.

References

WHO (World Health Organization). Global Hepatitis Report 2022. – Официальный сайт ВОЗ.

Министерство здравоохранения Российской Федерации. Клинические рекомендации по диагностике и лечению гепатита C у детей и подростков, 2023.

EASL (European Association for the Study of the Liver). Recommendations on Treatment of Hepatitis C 2022. – Journal of Hepatology, 2022, 76(4), 1041–1060.

Pawłowska, M., Halota, W., & Zaucha-Prażmo, A. (2021). “Hepatitis C in children and adolescents: epidemiology and treatment.” Przegl Epidemiol, 75(2), 181–188.

Schwarz, K. B., et al. (2021). “Treatment of chronic hepatitis C in children and adolescents.” Journal of Pediatric Gastroenterology and Nutrition, 73(4), 498–505.

González-Peralta, R. P., & Jonas, M. M. (2020). “Pediatric hepatitis C infection: a review for clinicians.” Pediatric Clinics of North America, 67(4), 645–658.